Research & Development: Page 63
-
UpFront
Chandler Chicco Co-Founder Receives SABRE Award Bob Chandler, principal and co-founder of the Chandler Chicco Companies, part of inVentiv Health, received a SABRE Award for Individual Achievement. Mr. Chandler received the award, which honors the exceptional work of public relations profession...
By PharmaVoice Team • Aug. 26, 2010 -
Letter from the Editor
Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing EDitor Denise Myshko Senior EDitor Robin Robinson features EDitor Kim Ribbink Contributing Editor Carolyn Gretton design associate Ariel Medel national account manager Cathy Tracy CIRCULATION Assistant Kathy Deiuliis C...
By Taren Grom • Aug. 26, 2010 -
Trendline
Oncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
Who's On The List by Section
The Commanders & Chiefs Johanna Allston, Ph.D. – bioCapture Vicente Anido Jr., Ph.D. – ISTA Pharmaceuticals Mara Aspinall – On-Q-ity Glenn Bilawsky – i3 Jay Bolling – Roska Healthcare David Brennan – AstraZeneca Nick Colucci – Publicis Healthcare – Communications Group Lynnette Cooke – Kantar...
By PharmaVoice Team • July 29, 2010 -
Lighter Moments
Michael Agard • Sanofi-Aventis US I was traveling for business in Paris with some colleagues. I had arranged a wake-up call with the hotel. My colleagues called about 1 a.m. to tell me about plans for the following day. Instead of listening to their phone call, I thought it was the wake-up call a...
By PharmaVoice Team • July 28, 2010 -
The Researchers & SCIENTISTS
A Diagnosis of Type 1 diabetes at the age of 6 and an early passion for science and research have propelled Randy Anderson, Ph.D., to become a force in the fight against the disease. Dr. Anderson has been making inroads into unraveling the mysteries of the disease since his senior-year zoology c...
By PharmaVoice Team • July 28, 2010 -
The ENTREPRENEURS
A New Breed of Explorer These stalwart captains of industry are taking their passion, innovation, and new ideas around improving the shortfalls within the industry to break new ground. Leslie Gaber started her company at her kitchen table with her 3 and 6 year old daughters by her side. Name: Les...
By PharmaVoice Team • July 28, 2010 -
The Commanders & CHIEFS
Johanna Allston, Ph.D. bioCapture Vicente Anido Jr., Ph.D. ISTA Pharmaceuticals Mara Aspinall On-Q-ity Glenn Bilawsky i3 Jay Bolling Roska Healthcare David Brennan AstraZeneca Nick Colucci Publicis Healthcare Communications Group Lynnette Cooke Kantar Health David Dunn ...
By PharmaVoice Team • July 28, 2010 -
Talent Pool
Pharma POOL Dr. Mike BURGESS, Roche Dr. Mikael DOLSTEN, Pfizer Kenneth FRAZIER, Merck Adam SCHECHTER, Merck Biotechnology POOL Robert BRADWAY, Amgen Dr. Henry LI, Kylin Therapeutics Kenneth MOCH, Chimerix Dr. George PAINTER, Chimerix Dr. Thomas PITLER, Chimerix Biopharmaceutical POOL Dr. John ALA...
By PharmaVoice Team • July 28, 2010 -
On The Calendar
July 15-16 Effective Document Management for the Pharmaceutical, Biotech & Medical Device Industries The Hilton Hotel, Orange County/ Costa Mesa, Calif. The Center for Professional Innovation and Education, http://www.cfpie.com/showitem.aspx?productid=027&source=pv July 15-16 Managed Care...
By PharmaVoice Team • July 28, 2010 -
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: FDA, NIH Launch Electronic Safety Reporting Portal Insurance Documentation System Helps Prevent Study Delays GSW Worldwide Unveils New Website and Blog Derycz Scientific Offers Solution for Electronic Article Reus...
By PharmaVoice Team • July 28, 2010 -
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Financial Disclosure Compliance is Still an Issue for Life-Sciences Firms Sidebars: Slow Outsourcing of Disclosure Reporting Sources for Adverse Event Reports Online Collection of Adverse Event Reports Lags Traditional M...
By PharmaVoice Team • July 28, 2010 -
Who's on the List by Company
Anavex Life Sciences Cameron Durrant, M.D. 18 ApotheCom David Dunn 16 Astellas Pharma US Margaret Long 73 AstraZeneca David Brennan 46 bioCapture Johanna Allston, Ph.D. 12 C3i Robert Piwko 112 Cegedim Dendrite Angela Miccoli 74 Cipla Ltd. Yusuf Hamied, Ph.D. 19 ClearTrial Mike Soenen 29 closerloo...
By PharmaVoice Team • July 28, 2010 -
Letter from the Editor
The PharmaVOICE 100: 2010 Every year, I think this is it, we’ve reached the pinnacle. And yet, every year, I continue to be amazed by the individuals whom our readers have identified as the most inspiring, motivating, and outstanding leaders in the life-sciences industry. This special issue, n...
By Taren Grom • July 28, 2010 -
Table of Contents
4 June 2 010 VIEW on Clinical Operations TAB LE OF CONTENTS Table of Contents 3 5 10 12 14 16 18 Letter from the Editor The Forum A Prescription for R&D Refills: Pharmaceutical and biotechnology drug developers appear to be making some progress in their perennial quest to bring more and bette...
By PharmaVoice Team • June 4, 2010 -
Innovating Imaging in Clinical Trials
Investigators engaged in drug or device discovery and development increasingly regard imaging modalities as technology to improve efficiencies, make faster go/no go decisions and reduce time-to-market. Beyond classic laboratory tests, medical images are raw datasets that empower the industry to i...
By PharmaVoice Team • June 4, 2010 -
Global Investigator Reimbursement and Protocol Complexity Trends
Some of the most significant trends in global clinical trial costs are occurring in the area of reimbursement for completed patients/subjects. Over the last five years, in phase II and III studies, reimbursement has increased globally by 30%. France and Germany show the highest percent increase, ...
By PharmaVoice Team • June 4, 2010 -
Finding the Best Clinical Trial Investigators
How many clinical trial investigators are in the United States, where are they, who are they, and how do you find the best ones? This article presents a newly completed project to answer these questions, and you will see comprehensive statistics that profile investigators. The best investigators ...
By PharmaVoice Team • June 4, 2010 -
A New World of Information Management and Collaboration
SharePoint has been adopted by more than 17,000 companies, and it has become Microsoft’s fastest-growing server product ever. There is good reason for this exponential growth — people across diverse industries find that it improves productivity and takes the knowledge worker to a new level of rea...
By PharmaVoice Team • June 4, 2010 -
A Prescription for R&D Refills
According to the Outlook 2010 report from the Tufts Center for the Study of Drug Development (CSDD), worldwide sales for all drugs coming off patent from 2009 through 2012 will exceed $88 billion. Drug developers and the U.S. Food and Drug Administration have worked hard to speed up the drug-deve...
By PharmaVoice Team • June 4, 2010 -
Supplier Showcase
BioClinica 826 Newtown-Yardley Rd. Newtown, PA 18940 Phone: 800-392-7456 Fax: 267-757-3010 www.bioclinica.com Discover the Power of a New Combination BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceut...
By PharmaVoice Team • June 4, 2010 -
Letter from the Editor
Social media — Facebook, LinkedIn, etc. — have infiltrated every aspect of our life, so it should be no surprise that these virtual connectors are changing the clinical trial arena. Recruiting patients for clinical trials, and retaining them once they’ve entered those studies, remain two of the t...
By PharmaVoice Team • June 4, 2010 -
ACRP 2010 Global Conference & Exhibition Wrap Up
The Association of Clinical Research Professionals (ACRP) remains steadfast in its mission to provide value and excellence to conference participants against a backdrop of continued economic and regulatory challenges to individuals and businesses. This year’s conference featured 55 sessions and 2...
By PharmaVoice Team • May 27, 2010 -
Adaptive by Design
Adaptive trial designs have the potential to speed development and reduce overall costs — that is, if sponsors invest in up-front planning and can implement these designs correctly. Interest in adaptive designs has risen in recent years. These types of studies involve a broad class of methods and...
By Denise Myshko • May 25, 2010 -
View on Diversity in Clinical Trials
Rapidly changing demographics are shifting the texture and fabric of American society. So-called niche markets have become “minority-majority" markets. Current healthcare reform that is focusing on better outcomes will only place more pressure on study sponsors to demonstrate to regulators that t...
By Kathleen B. Drennan • May 24, 2010 -
Dr. Nancy Simonian: One for All
There’s no place for the arch ego in today’s most progressive biotechnology companies or for that matter, at pharmaceutical companies. Rather, scientific leaders such as Nancy Simonian, M.D., are leading the charge toward collaborative ingenuity. Teamwork is very much Dr. Simonian’s mantra. Indee...
By Kim Ribbink • May 24, 2010